Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-8548
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumari, Jyoti-
dc.contributor.authorDas, Kinnor-
dc.contributor.authorPatil, Anant-
dc.contributor.authorBabaei, Mahsa-
dc.contributor.authorCockerell, Clay J.-
dc.contributor.authorGoldust, Mohamad-
dc.date.accessioned2023-01-25T08:46:43Z-
dc.date.available2023-01-25T08:46:43Z-
dc.date.issued2022-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/8564-
dc.description.abstractBackground: Cutaneous sarcomas are uncommon cancers that can have a wide range of clinical symptoms and lead to considerable cutaneous as well as systemic morbidity.Aim: The objective of this review article is to discuss epidemiology, clinical features, diagnosis, and therapy of different types of cutaneous sarcomas.Material and methods: Literature was screened to retrieve articles from PubMed/Medline and Google Scholar and related websites. Cross- references from the relevant articles were also considered for review. Review articles, clinical studies, system-atic reviews, meta-analyses, and relevant information from selected websites were included.Results and discussion: Cutaneous sarcomas have a negative effect on the quality of life. In their diagnosis, clinical presentation and histological evaluation are crucial. Complete surgical removal is the solution for more or less all cutaneous and subcuta-neous sarcomas. The prognosis for cutaneous sarcomas is generally favorable since they tend to recur locally with distant metastases only on rare occasions. Patients having advanced disease should be treated in the setting of clinical trials if possible; choices include radiation therapy and systemic medicines. The value of innovative im-munotherapy cannot be determined decisively at this time due to a paucity of relevant trials.Conclusion: As cutaneous sarcomas are rarely diagnosed based on clinical findings, histology plays an important role in the diagnosis. They have a relatively favorable prognosis if treated properly. Patients should be treated at specialized centres.en_GB
dc.description.sponsorshipGefördert durch die Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 491381577de
dc.language.isoengde
dc.rightsCC BY-NC*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleClinical update on cutaneous and subcutaneous sarcomasen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-8548-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleJournal of cosmetic dermatologyde
jgu.journal.volumeVersion of Record (VoR)de
jgu.publisher.year2022-
jgu.publisher.nameWiley-Blackwellde
jgu.publisher.placeOxfordde
jgu.publisher.issn1473-2165de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1111/jocd.15369de
jgu.organisation.rorhttps://ror.org/023b0x485-
jgu.subject.dfgLebenswissenschaftende
Appears in collections:DFG-491381577-H

Files in This Item:
  File Description SizeFormat
Thumbnail
clinical_update_on_cutaneous_-20230111094457958.pdf763.44 kBAdobe PDFView/Open